CHESTER, NJ and MONTREAL -- (MARKET WIRE) -- May 03, 2007 -- Molecular Biometrics, LLC, a privately held metabolomics company, presented results of a pilot study to identify diagnostic biomarkers for idiopathic Parkinson's Disease (PD) at the American Academy of Neurology's 59th Annual Meeting in Boston, MA.
